AAPL   321.89 (+1.24%)
FB   231.91 (+3.03%)
GOOGL   1,434.61 (+0.08%)
NVDA   352.25 (-0.78%)
CGC   16.44 (-5.35%)
BABA   206.56 (-0.40%)
MU   47.43 (-1.00%)
GE   6.56 (-0.15%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.94 (+0.26%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.48 (-3.02%)
NFLX   425.92 (+1.47%)
BAC   24.22 (+0.41%)
BA   151.38 (+3.79%)
AAPL   321.89 (+1.24%)
FB   231.91 (+3.03%)
GOOGL   1,434.61 (+0.08%)
NVDA   352.25 (-0.78%)
CGC   16.44 (-5.35%)
BABA   206.56 (-0.40%)
MU   47.43 (-1.00%)
GE   6.56 (-0.15%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.94 (+0.26%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.48 (-3.02%)
NFLX   425.92 (+1.47%)
BAC   24.22 (+0.41%)
BA   151.38 (+3.79%)
AAPL   321.89 (+1.24%)
FB   231.91 (+3.03%)
GOOGL   1,434.61 (+0.08%)
NVDA   352.25 (-0.78%)
CGC   16.44 (-5.35%)
BABA   206.56 (-0.40%)
MU   47.43 (-1.00%)
GE   6.56 (-0.15%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.94 (+0.26%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.48 (-3.02%)
NFLX   425.92 (+1.47%)
BAC   24.22 (+0.41%)
BA   151.38 (+3.79%)
AAPL   321.89 (+1.24%)
FB   231.91 (+3.03%)
GOOGL   1,434.61 (+0.08%)
NVDA   352.25 (-0.78%)
CGC   16.44 (-5.35%)
BABA   206.56 (-0.40%)
MU   47.43 (-1.00%)
GE   6.56 (-0.15%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.94 (+0.26%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.48 (-3.02%)
NFLX   425.92 (+1.47%)
BAC   24.22 (+0.41%)
BA   151.38 (+3.79%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 AgronomicsRhinomedPrescient TherapeuticsImmuronCAN-FITE BIOPHA/S
SymbolLON:ANICASX:RNOASX:PTXASX:IMCNYSEAMERICAN:CANF
Price Information
Current PriceGBX 7.01A$0.07A$0.04A$0.09$2.07
52 Week RangeN/AN/AN/AN/ABuy
Beat the Market™ Rank
Overall Score0.61.10.60.51.3
Analysis Score0.00.00.00.03.5
Community Score2.52.62.82.72.8
Dividend Score0.00.00.00.00.0
Ownership Score0.03.00.00.00.0
Earnings & Valuation Score0.60.00.00.00.0
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/ABuy
Consensus Price TargetN/AN/AN/AN/A$5.00
% Upside from Price TargetN/AN/AN/AN/A141.76% upside
Trade Information
Market Cap£16.01 million$12.35 million$17.35 million$15.06 million$15.61 million
BetaN/AN/AN/AN/AN/A
Average VolumeN/A122,418N/AN/A952,553
Sales & Book Value
Annual Revenue£-44,040.00$3.67 million$1.54 million$2.97 millionN/A
Price / Sales-401.333.3611.295.08N/A
CashflowGBX 13.35 per shareA$0.02 per shareA$0.02 per shareA$0.03 per shareN/A
Price / Cash0.533.481.913.15N/A
Book ValueGBX 13.90 per shareA$0.04 per shareA$0.03 per shareA$0.04 per shareN/A
Price / Book0.011.971.382.18N/A
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSGBX (1.30)A($0.06)A($0.01)A($0.03)N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A10.36%N/A2.60%N/A
Current Ratio119.70%2.99%15.64%4.42%N/A
Quick Ratio119.70%2.58%15.44%3.84%N/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/A5.12%
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
EmployeesN/AN/AN/AN/A7
Shares Outstanding252.14 million169.21 million394.26 million177.22 million8.67 million
Next Earnings DateN/AN/AN/AN/A6/1/2020 (Confirmed)
OptionableNot OptionableNot OptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.